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Abstract
Background: Evidence-based policy (EBP), a concept modelled on the principles of evidence-based medicine
(EBM), is widely used in different areas of policymaking. Systematic reviews (SRs) with meta-analyses gradually
became the methods of choice for synthesizing research evidence about interventions and judgements about
quality of evidence and strength of recommendations. Critics have argued that the relation between research
evidence and service policies is weak, and that the notion of EBP rests on a misunderstanding of policy processes.
Having explored EBM standards and knowledge requirements for health policy decision-making, we present an
empirical point of departure for discussing the relationship between EBM and EBP.
Methods: In a case study exploring the Norwegian Knowledge Centre for the Health Services (NOKC), an
independent government unit, we first searched for information about the background and development of the
NOKC to establish a research context. We then identified, selected and organized official NOKC publications as an
empirical sample of typical top-of-the-line knowledge delivery adhering to EBM standards. Finally, we explored
conclusions in this type of publication, specifically addressing their potential as policy decision tools.
Results: From a total sample of 151 SRs published by the NOKC in the period 2004–2013, a purposive subsample
from 2012 (14 publications) advised major caution about their conclusions because of the quality or relevance of
the underlying documentation. Although the case study did not include a systematic investigation of uptake and
policy consequences, SRs were found to be inappropriate as universal tools for health policy decision-making.
Conclusions: The case study demonstrates that EBM is not necessarily suited to knowledge provision for every kind
of policy decision-making. Our analysis raises the question of whether the evidence-based movement, represented
here by an independent government organization, undertakes too broad a range of commissions using strategies
that seem too confined. Policymaking in healthcare should be based on relevant and transparent knowledge,
taking due account of the context of the intervention. However, we do not share the belief that the complex and
messy nature of policy processes in general is compatible with the standards of EBM.
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Background
Knowledge is an essential foundation for informed deci-
sions in healthcare policy, and there is broad agreement
that best available research evidence should be used
[1-3]. However, what constitutes best available research
evidence for this purpose? In combination with the vast
amount of available information, an increasing expect-
ation that decisions should be transparent to be expli-
citly justified has led to the notion of evidence-based
policy (EBP), modelled on the principles of evidence-
based medicine (EBM) [1,2]. This article explores the re-
lationship between these two concepts.
In 1971, the Scottish epidemiologist Archie Cochrane
(1909–1988) [4,5] raised concerns about effectiveness,
efficiency and equality in healthcare, calling for random-
ized control trials (RCT) as the gold standard of evi-
dence [4]. His ideas were endorsed by the Canadian
epidemiologist David Sackett (1934–2015), who encour-
aged careful evaluation of health interventions to im-
prove the effectiveness of medical care [5]. From this
background emerged the concept of EBM, defined as
“the conscientious, explicit, and judicious use of current
best evidence in making decisions about the care of indi-
vidual patients” [6]. The aim was to close the gap be-
tween evidence and practice, making it possible to
evaluate health services on the basis of scientific evi-
dence rather than on clinical impression, anecdotal ex-
perience, ‘expert’ opinion or tradition [7,8].
Systematic reviews (SRs)
SRs with meta-analyses gradually became the methods
of choice for synthesizing research evidence, with further
development of systematic approaches for judging qual-
ity of evidence and strength of recommendations beyond
intervention studies [7,9-11]. Standard procedures for
SRs of health interventions are presented in the
PRISMA Statement [12-14], in which transparency with
regard to search strategy, inclusion criteria and data ex-
traction is considered crucial. The SR should therefore
contain explicit statements of questions addressed with
reference to participants, interventions, comparisons,
outcomes and study design (PICOS). The quality of evi-
dence and the strength of recommendations are system-
atically assessed using the Grading of Recommendations
Assessment, Development and Evaluation (GRADE) sys-
tem [9].
EBM and a broad range of SRs formed the basis for
development and implementation of various guidelines
for clinical practice [8]. EBM had also been established
to provide evidence for health policy decision-making.
In Great Britain, Tony Blair’s Labour government em-
phasized rigorous scientific analysis as a knowledge base
for improved policymaking, and a white paper from
1999 advanced the concept of EBP [15]. According to
EBP, research evidence should meet the requirements of
the EBM principles and hierarchy of evidence preferring
RCTs in support of health policy [1,4,8,16]. However,
transfer of the ‘evidence based’ concept from clinical
practice to health policy has not been straightforward
[1]. Critics have, for example, argued that the relation
between research evidence and service policies is weak
[3] and that the notion of EBP rests on a gross misun-
derstanding of policy processes [2]. While some policy
decisions are simple and lucid, others are complex or in-
coherent. We therefore sought to explore EBM stan-
dards and knowledge requirements for health policy
decision-making. In this article, we present an empirical
basis for such discussions, focused on the relationship
between EBM and EBP.
In Norway, the links between EBM and EBP were in-
stitutionalized in 2004 with the establishment of the
Norwegian Knowledge Centre for the Health Services
(NOKC). The details of the process are described in an
anniversary monograph [17]. This organization presents
a unique opportunity to study EBM as operated by a
government unit whose knowledge deliveries are
intended to enhance health policy decision-making. We
conducted a case study of the NOKC as a point of de-
parture for our research.
Methods
To begin, we will describe our overall research design
and strategy [18], followed by a description of the study
context. Finally, in this section, we present our proce-
dures for the systematic collection and analysis of empir-
ical data.
Research design and strategy
The case study was conducted in three phases. First, we
searched for information describing the background,
tasks, organizational framework, establishment, values
and development of the NOKC to define the study con-
text. In the second phase, we identified, organized and
selected official publications from the NOKC, establish-
ing an empirical sample of typical top-of-the-line know-
ledge deliveries adhering to EBM principles and
standards. In the third phase, we explored the conclu-
sions drawn in this type of publication, specifically ad-
dressing their potential as policy decision-making tools.
Our analysis provided arguments for a critical discussion
of EBP and its underlying assumptions.
Study context: the NOKC
In Norway, adoption of EBM was officially enacted in
2004 with the establishment of the NOKC, an independ-
ent government unit administered by the Norwegian
Directorate of Health [19]. The establishment of the
NOKC was based on “a need to enhance the
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underpinning of decisions in ministries, directorate and
regional health enterprises to improve achievement of
aims within health policy and encounter future profes-
sional challenges” [19] (our translation, p. 98). Resources
were assembled by merging three existing health service
research units outside the universities, including a group
of researchers who established the Norwegian branch of
the Nordic Cochrane Centre. The initial annual budget
of the NOKC in 2004 was NOK 33.8 million, increasing
to NOK 182 million in 2014 [20]. Reviewing the avail-
able documentation, we have compared the priority aims
and practices of the NOKC to established EBM stan-
dards [4,6,8,21-24]. We also particularly searched for au-
thoritative demonstrations of epistemological positions
and institutional preferences with regard to knowledge
deliveries.
According to the anniversary monograph, the NOKC’s
two core activities in its first decade were (1) knowledge
synthesis (different types of SRs) and (2) monitoring
(quality assessments, user satisfaction surveys) [17].
Other activities of the NOKC include strategies for
methodological innovation and implementation of EBM
in developing countries [25,26]. In the present study, we
focused on activities related to knowledge synthesis,
which was estimated to account for 25% of the institu-
tion’s total person hours in 2012 [17] (p. 176). NOKC
strategies for knowledge synthesis have been explicitly
drawn from EBM, with reference to methods from the
Cochrane Collaboration [27]. In addition, the NOKC
website exhibits a broader conceptual perspective, pro-
moting an ideology of knowledge-based practice as a
balance between research evidence, experience-based
knowledge and patient values and preferences [28].
Collection and analysis of empirical data: selected
publications from NOKC 2004–2013
In October 2014, we conducted a systematic examin-
ation of all publications presented on NOKC’s website,
reflecting the organization’s tasks, priorities and know-
ledge deliveries. SRs complying with EBM standards
were the highest-ranked delivery format [9,11,29].
To identify SRs from NOKC’s website, we applied the
organization’s own taxonomy of publication types. From
our searches, it became clear that publications other
than those classified as SR also contained elements of
SR methodology. This overlap with well-defined SRs was
noticed in publications classified as health technology
assessments, brief reviews and reviews with sorted litera-
ture. The most consistent EBM-compatible methodology
was identified in publications classified by NOKC as
SRs. Publications in this category from the period 2004–
2013 were therefore chosen as a purposive sample from
which to explore links and relations between EBM and
EBP.
The sample was organized to reflect the number and
type of NOKC-produced SRs, contextualized in terms of
total output during these years. As the NOKC webpages
offered no consistent thematic classification of SRs, we
developed four categories to provide a rough overview
of health areas covered by these publications: (1) screen-
ing/diagnosis; (2) treatment/medication/vaccination; (3)
prevention/psychosocial interventions; and (4) initiatives
within health and social services. In March 2015, we
noted that the NOKC had totally revised their website,
including their classification of publication types. While
we found complete agreement for lists of SRs for the
period 2007–2013, our lists for the years 2004–2006 had
to be adjusted to reflect the new NOKC scheme. While
still providing relevant information for our purposes, we
concluded that the quantitative accuracy of this ap-
proach to data collection would be moderate, while still
providing relevant information for our purpose. How-
ever, it was no longer possible to sort the full range of
publications by type, as the original taxonomy had not
been consistently applied by the NOKC.
We then conducted a formative qualitative evaluation
[30] of SRs from a random recent year (2012). More spe-
cifically, we reviewed the conclusions of this subsample
of reports to explore their potential as evidence to sup-
port informed healthcare policy decision-making. Draw-
ing on perspectives from the rhetorics of health and
medicine, we assessed the persuasive power of the con-
clusions mediated by the language used, especially with
regard to terms indicating positions of certainty or reluc-
tance [31]. This process was conducted by systematic
negotiation between the authors in pursuit of consensus.
The summary of quantitative results below displays
the number, proportion and distribution (annual and
thematic) of SRs from the NOKC. We then report our
findings on the potential of these SRs in support of
health policy decision-making.
Results
During the period 2004–2013, the NOKC produced
1,570 publications in total, including SRs, systematic lit-
erature searches, sorted brief reviews, reports from the
Knowledge Centre, reports from GRUK (quality im-
provement), reports from PasOpp (patient experiences),
memorandums, health technology assessments and
other published material (Fig. 1). During that decade, a
total of 151 SRs were published (annual range 6–22, me-
dian 14.5), representing 6–21% of NOKC’s annual out-
put. The highest proportion of these came from the
institution’s first years of activity (2005 and 2006); since
that time, the level has remained stable.
The thematic distribution of SRs is shown in Fig. 2.
The majority of SRs were related to treatment/medica-
tion/vaccination, followed by prevention/psychosocial
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interventions, advances in health and social services and
screening/diagnosis.
Based on our review, 2012 was found to be a fairly
typical year (Fig. 3).
During 2012, the NOKC published 14 SRs. Within this
sample, six SRs dealt with prevention/psychosocial inter-
ventions, five with treatment/medication/vaccination and
three with advances in health and social services. None of
that year’s SRs dealt with screening/diagnosis. Commis-
sions came from government directorates (n = 6), trade
unions for health professionals (n = 4), hospitals (n = 3)
and the Norwegian Cancer Society (n = 1).
Altogether, 57,368 studies were screened to produce a
total of 351 studies for synthesis in 2012. The average
number of initial records identified for each SR was
4,098 (range 263–10,188), and the average number of in-
cluded studies for each SR was 25 (range 3–91). While
most of the included studies were SRs, some used RCTs
or observational studies as their point of departure
(Table 1). In this sample of 14 SRs, we observed that the
major rhetorical pattern in the conclusions advocated
caution in various forms. In some reviews, such as one
relating to list size and quality of care among general
practitioners, no relevant effect studies were identified.
In a majority of SRs, some documentation had been re-
trieved, but this consisted predominantly of studies,
often few, small or old, with heterogeneity of interven-
tion types. Terms like ‘moderate’, ‘low’ or ‘very low
Fig. 1 Annual number of publications from the Norwegian Knowledge Centre for the Health Services (2004–2013).
Fig. 2 Themes covered by systematic reviews (total numbers) from the Norwegian Knowledge Centre for the Health
Services (2004–2013).
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quality’ occurred frequently with reference to the avail-
able documentation. These classifications seem to be
drawn from standard ratings of evidence quality [9]. Sev-
eral of the conclusions strongly recommend caution re-
garding interpretation because of risk of bias, indicating
the possibility of systematic skewness and low validity of
results. While some of the SRs stated that no certain
conclusions could be drawn, others employed a striking
level of cautious terminology in presenting their conclu-
sions, such as ‘probably increases’, ‘possibly increases’,
Fig. 3 Systematic reviews (annual number and distribution of themes) from the Norwegian Knowledge Centre for the Health
Services (2004–2013).
Table 1 Systematic reviews (themes, titles, total hits and included studies) from the Norwegian Knowledge Centre for the Health
Services (2012)







18-2012 Psychological treatments for non-specific pain 4,300 6 SR
17-2012 Effect of multidisciplinary, team-based rehabilitation, including education,
in rheumatoid arthritis
1,441 11
13-2012 Effect of long-term mechanical ventilation (LTMV) part 1 – neuromuscular disease or
central respiratory failure
5,442 34 (1 SR, 3 RCT)
14-2012 Effects of LTMV part 2 – thoracic restrictive disorders or obesity hypoventilatory syndrome 6,978 33 (2 RCT)
02-2012 The effects of sexual therapy interventions for sexual problems 2,805 43 (9 SR, 34 RCT)
Prevention/Psychosocial
interventions
12-2012 Effects of organised follow-up of behaviour that may increase risk of disease in adults 10,188 23
08-2012 Effect of interventions to ease transitions for children and adolescents with disabilities 263 3 SR
07-2012 The effectiveness of primary interventions to prevent the use of tobacco, alcohol
and other drugs among children and adolescents
4,518 10 SR
06-2012 The effectiveness of health promotion and preventive interventions on nutrition,
physical activity, obesity, and sexual health in children and adolescents
4,518 6 SR
10-2012 Effects of support and follow-up interventions for people with severe mental illness 2,674 17 SR
03-2012 Interventions for tobacco control in low- and middle-income countries: evidence
from randomised and quasi-randomised studies
2,806 45 (26 RCT)
Initiatives within health
and social services
05-2012 Effects of organisational interventions for mental health services 4,258 17 SR
01-2012 List size and quality of care among general practitioners within the Regular General
Practitioner Scheme
3,806 0/91a
09-2012 Interventions for reducing seclusion and restraint in mental health for adults 3,361 12
a No effect studies, 91 observational studies
SR, Systematic reviews; RCT, Randomized controlled trials
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‘increases perhaps’, ‘may reduce’, ‘uncertain’, ‘difficult to
conclude’. This terminology apparently reflected the rat-
ing system.
Only one of these 14 SRs from 2012 (dealing with in-
terventions to prevent use of tobacco, alcohol and drugs
among children and adolescents (07-2012)) concluded
that extensive and high quality documentation had been
identified. While the report identified a range of effective
interventions, the language of caution again appeared (e.
g. ‘possibly effective’, ‘likely not effective’). Another re-
lated SR, dealing with interventions regarding nutrition,
physical activity, obesity and sexual health in children
and adolescents (06-2012), reported that substantial
documentation allowed the authors to draw some con-
clusions. Nevertheless, they expressed some reservations
about the broad scope of the documentation, which
meant that the recommended interventions were at a ra-
ther general level. For the remaining 12 SRs, the authors’
conclusions are characterized in every case by an over-
arching caution.
Discussion
A major task for the NOKC as an independent govern-
ment organization is to provide knowledge that will
underpin health policy decisions [19]. Institutional strat-
egies are clearly influenced by EBM values and methods
[17], installing SRs as the most valued format for know-
ledge delivery [32]. From a total sample of 151 SRs pub-
lished by the NOKC in the period 2004–2013, our
purposive subsample served to demonstrate that most of
these reports advised major caution in relation to their
conclusions owing to the quality or relevance of the
underlying documentation. Although our case study did
not include a systematic investigation of uptake and pol-
icy consequences, it became apparent that SRs are not
appropriate universal tools for health policy decisions.
Below, we discuss the impact of these findings.
EBM in clinical decision-making
EBM was developed as a strategy to inform patient care
as well as health policy decisions. We are not the first to
suggest that the evidence hierarchy of EBM, which gives
precedence to quantifiable and supposedly universal
knowledge, may be too confined to meet the needs of
clinical decision-making in respect of the individual pa-
tient [33,34]. Resistance to this confined conception of
evidence was expressed by members of clinical disci-
plines where experientially based, tacit knowledge is re-
quired, as distinct from the formal knowledge offered by
science [35]. Similar arguments regarding the nature of
knowledge had previously been articulated from general
practice researchers, with regard to the limitations of
universal knowledge and the impact of particular and in-
dividualized knowledge in clinical practice [33,36-40].
Approaching clinicians, the NOKC has invested consid-
erable resources in implementation, with courses, web-
sites and organized access to research literature for
healthcare professionals. The centre has conceptualized
a platform for knowledge-based practice in which main-
stream EBM is integrated with the experience-based and
user-based knowledge in a local context [17].
Pope described EBM as a contemporary social move-
ment with a high profile, although not overly successful
[35]. After a decade of operation, the values of the EBM
movement and the corresponding evidence hierarchy are
still embraced by the NOKC [17]. The original idea of
integrating individual clinical expertise with best evi-
dence [6] seems to have gradually vanished in the
shadow of meta-analyses, RCTs and algorithmic rules
[34,41]. Procedures for the assessment and synthesis of
qualitative evidence have recently been included among
EBM standards and tools by the Cochrane Collaboration
[42], but such approaches were not prominent in the
sample of SRs we explored.
We find it plausible that EBM principles applied in
SRs that synthesize current research knowledge in a
standardized and transparent format may well enhance
clinical decision-making. However, the tool seems most
appropriate and capable of providing a clear answer
when the research question fits the hierarchy of evidence
and the PICO formula [9,12]. A typical example would
be whether medication X is a better treatment than
medication Y for patients suffering from a single and
well-defined disease, as in the prevention of eye infection
after cataract surgery [43]. Another example of the tool’s
appropriateness would be to ask whether test Z as ap-
plied to a defined population will have an impact on
morbidity or mortality (disease-specific or all-cause, re-
spectively) for tests and conditions such as prostate-
specific antigen and prostate cancer [44].
In clinical practice, however, such clear-cut decision
spaces rarely exist, especially in the primary healthcare
setting, where multimorbidity is commonplace [45]. This
is probably one important reason for the limited compli-
ance among general practitioners to EBM-based
guidelines [46]. The challenges of EBM-based clinical
decision-making become more apparent in complex and
behavioural interventions in more heterogeneous popu-
lations, as in most of the sample we examined.
EBM as a tool to guide health policy decisions
Our exploration of EBM indicates its shortcomings as a
tool for clinical practice, in that its universal and standard-
ized evidence base fails to address the particular question
and context for decision-making. These concerns are no
less valid in assessing EBM as a tool for policy decision-
making (even though the current Cochrane terminology
refers to evidence-informed health decision-making) [47].
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Dobrow et al. [48] emphasize current conceptual deficien-
cies and the limited attempts to acknowledge the role of
context in evidence-based decisions. To understand the
complex adaptive nature of health systems, the context,
acceptability and feasibility of interventions must be
highlighted [49]. Mixed-methods approaches have been
proposed as a means of studying complex health systems
at patient, provider, institutional and system levels
[26,42,50,51]. To date, however, our sample of SRs from
2012 indicates little attention to contextual or qualitative
matters in NOKC knowledge deliveries.
Even with better research studies and more solid
conclusions than those of our sample from 2012, pol-
icy decision-making processes demand much more
than knowledge translation, defined by WHO as “the
synthesis, exchange and application of knowledge by
relevant stakeholders to accelerate the benefits of glo-
bal and local innovation in strengthening health sys-
tems and advancing people’s health” [52]. This
conception represents the ‘know-do’ gap to be bridged
between scientific facts and policymaking as a simple
pipeline model, in which incoming evidence under-
pins decisions [53,54]. Our analysis of the available
empirical data suggests that, if such a pipeline were
operating, the flow of conclusions and corresponding
policy decisions would be very low.
Knowledge deliveries that repeatedly communicate a
broad lack of quality evidence across most tasks may in-
dicate the inadequacy of standard tools for a government
unit commissioned to enhance decision-making. One
hypothesis arising from our empirical analysis is that the
NOKC (and, probably, comparable institutions within
the EBM movement) addresses too broad a range of in-
quiries, using too confined a range of tools. The main
problem with the EBM approach is its restricted and
simplistic approach to scientific knowledge [55]. The
standardizing imperative that underpins EBM strategies
is neither compatible with all questions of relevance for
policymaking nor with scientific reasoning. It would be
interesting to look more closely at the decision-making
processes and the role of the authorities in how assign-
ments are accepted, modified or dismissed. Knowledge
is always situated [56]. The NOKC SRs are no exception,
informing both the question asked and the consequences
of the answer.
In a critical analysis of evidence-based policy research,
Oliver et al. [54] concluded that many approaches within
this area are naïve in neglecting how policy is influenced
and constituted. They point to a loss of clarity about what
constitutes and defines ‘evidence’ and ‘policy’, neglecting
“the policy process itself as a contested area of negotiation”
and “the messy, complex, and serendipitous nature of policy-
making” [54]. Comparing three SRs on EBP research, Oliver
et al. [54] argue that, without an understanding of the
complex processes of policy and knowledge mobilization,
researchers who make policy and practice recommenda-
tions will simply be ignored. Orton et al.’s [1] SR of the use
of research evidence in public health decision-making
processes also concluded that the impact of research evi-
dence was often indirect and had to compete with other
influences.
We believe that current EBM-based NOKC studies seek
to provide a legitimate basis for health policy decision-
making in Norway, and we endorse the idea that certain
domains of inquiry may be well suited to such approaches.
However, given the large proportion of recent NOKC de-
liveries that lack substantial conclusions, we must also re-
flect on the potential policy consequences of ‘empty’
knowledge deliveries. As a broad range of complex inter-
ventions cannot be adequately evaluated by the EBM for-
mat, there will be limited availability of ‘authorized’
research documentation, and SRs will be unable to offer
strong conclusions about positive effects. This is not the
same as documentation of negative or zero intervention
effects. Often, the issues leading to SR commissions are
controversial, and the delivery is expected to recommend
a direction or choice. The present findings highlight the
possibility of policy decision-making in which political in-
terests (as in “this government does not want to support
such a reform”) may be legitimized by SRs that draw weak
or deficient conclusions, which are then interpreted as
evidence-based warnings against the intervention in ques-
tion. In this way, the EBM evidence hierarchy may actually
contribute to concealing the foundation of policy
decision-making rather than providing transparency.
Conclusions
In this case study exploring selected publications from
the NOKC, we have demonstrated that EBM is not uni-
versally suited to knowledge provision for every kind of
health policy decision-making. Our analysis raises the
question of whether the EBM, represented here by an in-
dependent government organization, undertakes too
broad a range of commissions using a range of strategies
that seem too confined. As far as possible, healthcare
policymaking should be based on relevant and transpar-
ent knowledge, taking account of the context of the
intervention. However, we do not share a belief that the
complex and messy nature of policy processes in general
is compatible with the standards of EBM.
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